Literature DB >> 3229028

Antibacterial antibody pattern in seronegative spondyloarthropathies (SNSA).

G Lapadula1, M Covelli, R Numo.   

Abstract

The occurrence of some anti-bacterial antibodies was studied in sera from 31 healthy donors (HD) and 101 patients with different rheumatic diseases. The cases investigated included 7 Psoriatic Arthritis (PA), 35 Rheumatoid Arthritis (RA), 17 Undifferentiated Seronegative Spondyloarthritis (U-SNSA), 13 Behçet's syndrome, 18 Enteric Arthropathies (EA), 7 Ankylosing Spondylitis (AS) and 4 Reiter's syndrome. A complement fixation test was carried out to detect the presence and to evaluate the titer of the specific antibodies against the relative bacterial antigens. The antigens used were prepared for the complement fixation test by Virion Laboratories: Yersinia Enterocolitica 0:3 type (YEC), Yersinia Pseudotuberculosis (YPT), Campylobacter Jejuni (CJ) and Campylobacter Intestinalis (CI), Chlamydia Trachomatis (CT). The results indicate a statistically significant difference between the HD group and the seronegative polyarthritis one (PA, U-SNSA, Behçet, EA, AS, Reiter as a whole) as far as antibody production against YEC, CI and YPT is concerned. On the contrary, a significant difference between the HD group and RA patients for specific anti bacterial antibodies was only found against CT. Further detailed analysis of the behavior of the antibody pattern in any disease groups was carried out to identify a possible specific and featured antibody profile for some given rheumatic disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229028

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

Review 1.  Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review.

Authors:  Telma Thrastardottir; Thorvardur Jon Love
Journal:  Rheumatol Int       Date:  2017-11-09       Impact factor: 2.631

2.  Antibodies to arthritis-associated microbes in inflammatory joint diseases.

Authors:  O Mäki-Ikola; M K Viljanen; S Tiitinen; P Toivanen; K Granfors
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.